每經AI快(kuai)訊，羅(luo)欣(xin)藥(yao)業（SZ 002793，收盤價(jia)：6.8元）5月(yue)(yue)10日晚間發布公(gong)(gong)(gong)告(gao)(gao)稱，羅(luo)欣(xin)藥(yao)業集團股(gu)(gu)份有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)(si)持(chi)(chi)股(gu)(gu)5%以上股(gu)(gu)東方(fang)秀寶及其一致行動人方(fang)東暉、溫嶺市大(da)任投(tou)資管理(li)有限(xian)(xian)公(gong)(gong)(gong)司(si)(si)(si)(si)合(he)計(ji)持(chi)(chi)有公(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)份約1.32億(yi)股(gu)(gu)，占(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)總(zong)股(gu)(gu)本(ben)(ben)比例為(wei)12.1%，其中(zhong)(zhong)大(da)任投(tou)資單獨(du)持(chi)(chi)有公(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)份約1044萬股(gu)(gu)，占(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)總(zong)股(gu)(gu)本(ben)(ben)比例為(wei)0.96%。大(da)任投(tou)資擬(ni)通(tong)過(guo)集中(zhong)(zhong)競(jing)價(jia)或(huo)大(da)宗(zong)交(jiao)(jiao)(jiao)(jiao)易方(fang)式合(he)計(ji)減持(chi)(chi)公(gong)(gong)(gong)司(si)(si)(si)(si)股(gu)(gu)份數(shu)量不(bu)超過(guo)約1044萬股(gu)(gu)，占(zhan)公(gong)(gong)(gong)司(si)(si)(si)(si)總(zong)股(gu)(gu)本(ben)(ben)比例為(wei)0.96%。其中(zhong)(zhong)，通(tong)過(guo)集中(zhong)(zhong)競(jing)價(jia)方(fang)式減持(chi)(chi)，將于本(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)披露日起15個(ge)(ge)交(jiao)(jiao)(jiao)(jiao)易日后(hou)的三(san)個(ge)(ge)月(yue)(yue)內進行；通(tong)過(guo)大(da)宗(zong)交(jiao)(jiao)(jiao)(jiao)易方(fang)式減持(chi)(chi)，將于本(ben)(ben)公(gong)(gong)(gong)告(gao)(gao)披露日起3個(ge)(ge)交(jiao)(jiao)(jiao)(jiao)易日后(hou)的三(san)個(ge)(ge)月(yue)(yue)內進行。

2022年1至12月份，羅欣藥(yao)業(ye)(ye)(ye)的營業(ye)(ye)(ye)收入構(gou)成為：醫(yi)藥(yao)商(shang)業(ye)(ye)(ye)占比56.37%，醫(yi)藥(yao)工業(ye)(ye)(ye)占比40.35%。

羅欣藥(yao)業的總經理(li)、董事(shi)長均是劉振騰，男，37歲，學歷背景為碩士。

道(dao)達(da)號(hao)（daoda1997）“個股(gu)趨勢”提醒：
1. 羅欣藥業近30日內北向資金持股量減少28.15萬股，占流通股比例減少0.48%；
2. 近30日內無機構對羅欣藥業進行調研；
3. 羅欣藥業上次發布減持公告是2022年05月23日，第二個交易日下跌6.8%，羅欣藥業近一年共發布2次減持類公告。
更多個股趨(qu)勢信息，請搜索微(wei)信公眾號(hao)“道(dao)達號(hao)”，回復“查詢”，領取免費查詢權限！

每經頭條(tiao)（nbdtoutiao）——

(記者 尹華祿)

免(mian)責(ze)聲明：本文內容與數據僅供參(can)考，不構成投資建(jian)議，使用(yong)前請核實(shi)。據此(ci)操作，風險自擔。